[Cancer, thromboembolia and antithrombotic therapy: is there an anticoagulant of choice?].

Scharf, R E

[Cancer, thromboembolia and antithrombotic therapy: is there an anticoagulant of choice?]. [electronic resource] - Deutsche medizinische Wochenschrift (1946) Nov 2011 - 2403 p. digital

Publication Type: Comparative Study; Journal Article; Review

1439-4413

10.1055/s-0031-1292063 doi


Anticoagulants--adverse effects
Heparin--administration & dosage
Heparin, Low-Molecular-Weight--adverse effects
Humans
Infusions, Intravenous
Injections, Subcutaneous
Long-Term Care
Neoplasms--complications
Patient Acceptance of Health Care
Randomized Controlled Trials as Topic
Secondary Prevention
Survival Analysis
Thrombin--antagonists & inhibitors
Venous Thromboembolism--drug therapy
Vitamin K--antagonists & inhibitors